Weight Management Peptides

The Weight Management Peptides category covers research peptides documented for effects on incretin signaling, body composition, glucose homeostasis, and energy metabolism in animal models. These compounds represent the cutting edge of metabolic research. Featured products include Semaglutide, a long-acting GLP-1 receptor agonist; Tirzepatide, a dual GLP-1 and GIP receptor agonist; the Retatrutide range in 10mg, 15mg, 20mg, 40mg, and 50mg formats for triple GLP-1/GIP/glucagon agonist dose-response studies; and AOD 9604, a selective lipolytic growth hormone fragment for adipose research. Used in models of obesity, type 2 diabetes, metabolic syndrome, and hepatic steatosis. All vials manufactured to 99%+ HPLC-verified purity, supplied as sterile lyophilized powder, shipped Canada-wide. Research use only — not for human consumption.